Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2015; 61(1): 83-90

MODIFICATION OF EXPERIMENTAL ROTENONE MODEL OF PARKINSON’S DISEASE

L.P. Voitenko, A.G. Nikonenko

    O.O.Bogomoletz Institute of Physiology of National Academy of Sciences of Ukraine, Kyiv
DOI: https://doi.org/10.15407/fz61.01.083


Abstract

A modification of experimental model of Parkinson’s disease is proposed presuming the stereotaxic infusion of rotenone solution using a special device into the cental part of substantia nigra (SN) pars compacta of adult Wistar rats. It was shown that 10 days after infusion of the neurotoxin the density of dopaminergic (DA) neurons in the infusion area drops nearly six-fold, to 20.2±3.2 neurons/mm2, with respect to the corresponding value in non-affected controlateral SN, 119.0±3.3 neurons/mm2. Electron microscopy has shown ultrastructural impairments in mitochondria of SN neurons in the infusion area displayed mainly as a cristae disarray. The absence of overall toxicity and selectivity of the brain tissue impairments provide an evidence that the proposed rotenone model modification is adequate and can be used to study the effects of DA neuronal degeneration typical of Parkinson’s disease.

Keywords: rotenone; in vivo model; Parkinson’s disease.

Full text: (PDF, in Ukrainian)

References

  1. Roeper J. Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci. 2013; 36(6): 336-42. CrossRef PubMed
    2.  
  2. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000; 25(1): 239-52. CrossRef  
  3. Tkachenko MN, Zozulya IS, Shapoval MV, Sagach VF. Parkinsonism: current concepts of pathogenesis and the possible ways to correct. Ukr Med J. 2000; 3: 9-14.
    4.  
  4. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl. 1971; 367: 49-68. CrossRef PubMed
    5.  
  5. Bloem BR, Irwin I, Buruma OJ, Haan J, Roos RA, Tetrud JW, Langston JW. The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J Neurol Sci. 1990; 97(2-3): 273-93.
    6.  
  6. Bove J, Perier C. Neurotoxin-based models of Parkinson's disease. Neuroscience. 2012; 211: 51-76. CrossRef PubMed
    7.  
  7. Alam M, Schmidt WJ. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behav Brain Res. 2004; 153(2): 439-46. CrossRef PubMed
    8.  
  8. Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis. 2009; 34(2): 279-90. CrossRef PubMed PubMedCentral
    9.  
  9. Dickman KG, Mandel LJ. Differential effects of respiratory inhibitors on glycolysis in proximal tubules. Am J Physiol. 1990; 258(6): 1608-15.
    10.  
  10. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000; 3(12): 1301-06. CrossRef PubMed
    11.  
  11. Borland MK, Trimmer PA, Rubinstein JD, Keeney PM, Mohanakumar K, Liu L, Bennett JP Jr. Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Mol Neurodegener. 2008; 3: 21. CrossRef PubMed PubMedCentral
    12.  
  12. Keeney PM, Xie J, Capaldi RA, Bennett JP Jr. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci. 2006; 26(19): 5256-64. CrossRef PubMed
    13.  
  13. Ferrante RJ, Schulz JB, Kowall NW, Beal MF. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res. 1997; 753(1): 157-62. CrossRef  
  14. Xiong N, Huang J, Zhang Z, Zhang Z, Xiong J, Liu X, Jia M, Wang F, Chen C, Cao X, Liang Z, Sun S, Lin Z, Wang T. Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease. PLoS One. 2009; 4(11): e7878.
    15.  
  15. Paxinos G, Watson Ch. The rat brain in stereotaxic coordinates. New York: Academic Press. 2006: 456 p.
    16.  
  16. Itoh K, Nakamura K, Iijima M, Sesaki H. Mitochondrial dynamics in neurodegeneration. Trends Cell Biol. 2013; 23(2): 64-71. CrossRef PubMed PubMedCentral
    17.  
  17. Goedert M, Jakes R, Crowther RA, Spillantini MG. Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy as α-synucleinopathies. Methods Mol Med. 2001; 62: 33-59. CrossRef  

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2025.